{
    "clinical_study": {
        "@rank": "74007", 
        "acronym": "Synchro-Neb", 
        "arm_group": [
            {
                "arm_group_label": "Breath-actuated vibrating mesh nebulizer", 
                "arm_group_type": "Experimental", 
                "description": "500 mg/4 mL of Amikacin solution delivered with an experimental breath-actuated vibrating mesh nebulizer associated with a single limb circuit ventilator."
            }, 
            {
                "arm_group_label": "Conventional vibrating mesh nebulizer", 
                "arm_group_type": "Experimental", 
                "description": "500 mg/4 mL of Amikacin solution delivered with a conventional vibrating mesh nebulizer (in continuous mode) associated with a single limb circuit ventilator."
            }
        ], 
        "brief_summary": {
            "textblock": "Using an adult lung bench model of non invasive ventilation, the aim of the study is to\n      compare an experimental system of breath-synchronized vibrating mesh nebulizer to a\n      conventional vibrating mesh nebulizer during non invasive ventilation in terms of inhaled\n      and lost doses."
        }, 
        "brief_title": "In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Respiratory Diseases", 
            "Lung Diseases", 
            "Cystic Fibrosis", 
            "COPD", 
            "Asthma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Asthma", 
                "Cystic Fibrosis", 
                "Fibrosis", 
                "Lung Diseases", 
                "Respiration Disorders", 
                "Respiratory Tract Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Not applicable (in vitro study)\n\n        Exclusion Criteria:\n\n          -  hypersensitivity (allergic) reactions to aminoglycosides"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "3", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02084043", 
            "org_study_id": "Synchro-Neb"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Breath-actuated vibrating mesh nebulizer", 
                    "Conventional vibrating mesh nebulizer"
                ], 
                "description": "500 mg/4 mL Amikacin nebulized using vibrating mesh nebulizer associated with a single limb bilevel ventilator. The nebulizations are considered as finished when there is no visible evidence of nebulization for a period of 30 seconds. The NIV is set with an IPAP of 15 cmH2O and EPAP of 5 cmH2O. The lung model is simulated with a respiratory rate of 15 cycles/minute", 
                "intervention_name": "Nebulization of Amikacin during NIV (RR: 15 cycles/minute)", 
                "intervention_type": "Drug", 
                "other_name": "Amikacine sulfate"
            }, 
            {
                "arm_group_label": [
                    "Breath-actuated vibrating mesh nebulizer", 
                    "Conventional vibrating mesh nebulizer"
                ], 
                "description": "500 mg/4 mL Amikacin nebulized using vibrating mesh nebulizer associated with a single limb bilevel ventilator. The nebulizations are considered as finished when there is no visible evidence of nebulization for a period of 30 seconds. The NIV  is set with an IPAP of 15 cmH2O and EPAP of 5 cmH2O. The lung model is simulated with a respiratory rate of 25 cycles/minute", 
                "intervention_name": "Nebulization of Amikacin during NIV (RR: 25 cycles/minute)", 
                "intervention_type": "Drug", 
                "other_name": "Amikacine sulfate"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Amikacin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "aerosol delivery", 
            "vibrating mesh nebulizer", 
            "breath-actuated nebulizer", 
            "non invasive ventilation", 
            "bilevel ventilator", 
            "single limb circuit ventilator", 
            "Amikacin"
        ], 
        "lastchanged_date": "March 27, 2014", 
        "location": [
            {
                "contact": {
                    "email": "jean-bernard.michotte@hesav.ch", 
                    "last_name": "Jean-Bernard Michotte, PhD student"
                }, 
                "contact_backup": {
                    "email": "gregory.reychler@uclouvain.be", 
                    "last_name": "Gregory Reychler, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1200"
                    }, 
                    "name": "University Hospital St Luc"
                }, 
                "investigator": [
                    {
                        "last_name": "Jean-Bernard Michotte, PhD student", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Jonathan Dugernier, PhD student", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Gregory Reychler, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "1011"
                    }, 
                    "name": "University of Health Sciences (HESAV)"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yverdon-les-Bains", 
                        "country": "Switzerland", 
                        "zip": "1401"
                    }, 
                    "name": "School of Gestion and Engineering Vaud (HEIG-VD)"
                }, 
                "status": "Withdrawn"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Switzerland"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "In Vitro Comparison of Continuous and Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation: Analysis of Inhaled and Lost Doses.", 
        "other_outcome": {
            "description": "The dose lost into the circuit (nebulizer included) assessed by residual gravimetric method", 
            "measure": "Estimated lost dose", 
            "safety_issue": "No", 
            "time_frame": "after 24 hours"
        }, 
        "overall_contact": {
            "email": "jean-bernard.michotte@hesav.ch", 
            "last_name": "Jean-Bernard Michotte, PhD student"
        }, 
        "overall_contact_backup": {
            "email": "gregory.reychler@uclouvain.be", 
            "last_name": "Gr\u00e9gory Reychler, PhD"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Health Sciences (HESAV)", 
                "last_name": "Jean-Bernard Michotte, PhD student", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Cliniques universitaires Saint-Luc, service des soins intensifs", 
                "last_name": "Jonathan Dugernier, PhD student", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "School of Gestion and Engineering Vaud (HEIG-VD)", 
                "last_name": "Enrico Staderini, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "School of Gestion and Engineering Vaud (HEIG-VD)", 
                "last_name": "Rares Rusu, MSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Cliniques universitaires Saint-Luc, service des soins intensifs", 
                "last_name": "Jean Roeseler, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Cliniques universitaires Saint-Luc, service de pneumologie", 
                "last_name": "Giuseppe Liistro, MD PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Cliniques universitaires Saint-Luc, service de pneumologie", 
                "last_name": "Gregory Reychler, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The inhaled dose assessed by residual gravimetric method", 
            "measure": "Inhaled dose", 
            "safety_issue": "No", 
            "time_frame": "after 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02084043"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Applied Sciences of Western Switzerland", 
            "investigator_full_name": "Jean-Bernard Michotte", 
            "investigator_title": "MSc, PhD Student", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The dose expelled in the ambient air through the exhalation port assessed by residual gravimetric method", 
            "measure": "Expiratory wasted dose", 
            "safety_issue": "No", 
            "time_frame": "after 24 hours"
        }, 
        "source": "University Hospital St Luc, Brussels", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Universit\u00e9 Catholique de Louvain", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Applied Sciences of Western Switzerland", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "School of Gestion and Engineering Vaud (HEIG-VD)", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University Hospital St Luc, Brussels", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}